EyePoint Pharmaceuticals Inc (PSDV):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:EyePoint Pharmaceuticals Inc (PSDV) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12134
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert is an injectable, miniaturized, sustained-release drug delivery system, used for the treatment of chronic diseases of the back of the eye. EyePoint’s iluvien is an injectable, non-erodible, intravitreal implant for the treatment of DME. The company provides drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. It operates in the US and the UK. pSivida is headquartered in Watertown, Massachusetts, the US.

EyePoint Pharmaceuticals Inc (PSDV) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
EyePoint Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
EyePoint Pharmaceuticals Inc, Medical Equipment, Deal Details 11
Partnerships 11
Alimera Sciences Enters into Licensing Agreement with pSivida 11
Enigma Therapeutics Amends Licensing Agreement with pSivida 12
Ocumension Therapeutics Enters into Licensing Agreement with EyePoint Pharma 13
Equity Offering 14
EyePoint Pharma Plans to Raise up to USD75 Million in Public Offering of Securities 14
EyePoint Pharma Raises USD28.9 Million in Private Placement in Shares upon Exercise of Warrants 15
EyePoint Pharma Plans to Raise Funds through Public Offering of Shares 16
EyePoint Pharma to Raise USD25.5 Million in Private Placement in Second Tranche of Units 17
EyePoint Pharma Raises USD9.5 Million in Private Placement of Securities 18
EyePoint Pharma Raises USD0.5 Million in Private Placement of Securities 19
pSivida Plans to Raise Upto USD20 Million in Public Offering of Shares 20
pSivida Raises USD17.8 Million in Public Offering of Shares 21
pSivida Raises USD7 Million in Private Placement of Shares 23
pSivida Announces Private Placement Of Shares For US$19 Million 24
pSivida Completes Public Offering Of Shares For US$10.8 Million 25
pSivida Completes Private Placement Of Units For US$5.4 Million 26
EyePoint Pharmaceuticals Inc – Key Competitors 27
EyePoint Pharmaceuticals Inc – Key Employees 28
EyePoint Pharmaceuticals Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Nov 06, 2018: EyePoint Pharmaceuticals reports fiscal first quarter 2019 financial results and highlights recent clinical and operational developments 30
Sep 12, 2018: EyePoint Pharmaceuticals reports fiscal 2018 fourth quarter & full year financial results and highlights recent progress 32
May 08, 2018: EyePoint Pharmaceuticals Reports Fiscal Third Quarter 2018 Results 35
Feb 07, 2018: pSivida Reports Second Quarter FY2018 Results; Continues to Achieve Milestones and Timelines 37
Nov 07, 2017: pSivida Builds Momentum During First Quarter FY18; Continues Operating Milestone Execution 38
Sep 11, 2017: pSivida Achieves Significant Milestones Throughout FY 2017; Reports Fourth Quarter and Fiscal 2017 Results 39
May 04, 2017: pSivida Reports Fiscal 2017 Third Quarter Results; Key Milestones on Track 40
May 04, 2017: pSivida Reports Fiscal 2017 Third Quarter Results 41
Feb 07, 2017: pSivida Reports Fiscal 2017 Second Quarter and First Half Results 42
Corporate Communications 44
Nov 27, 2018: EyePoint Pharmaceuticals names Ron Honig, Esq., as SVP, general counsel & company secretary 44
Oct 30, 2018: EyePoint Pharmaceuticals appoints John Landis, Ph.D., M.S., to Board of Directors 45
Sep 10, 2018: EyePoint Pharmaceuticals names Goran Ando as Next Chairman of Board of Directors 46
Aug 15, 2018: Eyepoint Pharmaceuticals appoints John Weet, Ph.D., as SVP, regulatory affairs & quality 47
Jun 26, 2018: EyePoint Pharmaceuticals Names Goran Ando As Board Director 48
May 16, 2018: EyePoint Pharmaceuticals Announces Appointment of Leonard Blum as Executive Vice President and General Manager, U.S. 49
Jun 28, 2017: pSivida Enhances Board of Directors with Election of Veteran Healthcare Executive Kristine Peterson 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Tables
EyePoint Pharmaceuticals Inc, Medical Equipment, Key Facts, 2018 2
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
EyePoint Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
EyePoint Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 9
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Alimera Sciences Enters into Licensing Agreement with pSivida 11
Enigma Therapeutics Amends Licensing Agreement with pSivida 12
Ocumension Therapeutics Enters into Licensing Agreement with EyePoint Pharma 13
EyePoint Pharma Plans to Raise up to USD75 Million in Public Offering of Securities 14
EyePoint Pharma Raises USD28.9 Million in Private Placement in Shares upon Exercise of Warrants 15
EyePoint Pharma Plans to Raise Funds through Public Offering of Shares 16
EyePoint Pharma to Raise USD25.5 Million in Private Placement in Second Tranche of Units 17
EyePoint Pharma Raises USD9.5 Million in Private Placement of Securities 18
EyePoint Pharma Raises USD0.5 Million in Private Placement of Securities 19
pSivida Plans to Raise Upto USD20 Million in Public Offering of Shares 20
pSivida Raises USD17.8 Million in Public Offering of Shares 21
pSivida Raises USD7 Million in Private Placement of Shares 23
pSivida Announces Private Placement Of Shares For US$19 Million 24
pSivida Completes Public Offering Of Shares For US$10.8 Million 25
pSivida Completes Private Placement Of Units For US$5.4 Million 26
EyePoint Pharmaceuticals Inc, Key Competitors 27
EyePoint Pharmaceuticals Inc, Key Employees 28
EyePoint Pharmaceuticals Inc, Subsidiaries 29

List of Figures
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
EyePoint Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[EyePoint Pharmaceuticals Inc (PSDV):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Bank of New York Mellon Corporation:企業のM&A・事業提携・投資動向
    The Bank of New York Mellon Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Bank of New York Mellon Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …
  • Reliance Steel & Aluminum Co:戦略・SWOT・企業財務分析
    Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Maruha Nichiro Corporation
    Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report Summary Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SonarMed Inc:医療機器:M&Aディール及び事業提携情報
    Summary SonarMed Inc (SonarMed) is a medical device company that develops endotrachael systems used for the inhalation and ventilation assistance patients. The company offers products such as artificial respiratory, endotrachael tubes, biomedical acoustics, SonarMed Airwave, medical devices, disposa …
  • Worldpay Us Inc
    Worldpay Us Inc - Strategy, SWOT and Corporate Finance Report Summary Worldpay Us Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • CCP Technologies Ltd (CT1)-医療機器分野:企業M&A・提携分析
    Summary CCP Technologies Ltd (CCP), formerly Agenix Ltd is a technology company that offers business-to-business hardware and software solutions. The company develops Internet of Things’ solutions for management of computers, smart phones, sensors and diverse equipment. It offers business hardware a …
  • Cascade Metrix LLC:企業の製品パイプライン分析
    Summary Cascade Metrix LLC (CMI) is a medical technology company that offers automated POC blood analyzer for critical care. The company offers novel micro-volume IV extension kits, and automated glucose monitoring systems, among others. It also provides a revolutionary ex vivo blood analysis system …
  • Key Energy Services, Inc.:企業の戦略・SWOT・財務分析
    Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Jardine Lloyd Thompson Group plc:企業のM&A・事業提携・投資動向
    Jardine Lloyd Thompson Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Jardine Lloyd Thompson Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • aap Implantate AG (AAQ):医療機器:M&Aディール及び事業提携情報
    Summary aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosyn …
  • Intrusion Inc (INTZ):企業の財務・戦略的SWOT分析
    Summary Intrusion Inc (Intrusion) is a technology company. The company offers network monitoring and analysis solutions. Its product portfolio includes Savant, TraceCop that enables identification of malicious and illegal activities, Secure Tap a suite of network tap products that enables deployment …
  • Norwegian Hull Club:企業の戦略・SWOT・財務情報
    Norwegian Hull Club - Strategy, SWOT and Corporate Finance Report Summary Norwegian Hull Club - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Kymab Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Kymab Ltd (Kymab) is a therapeutic antibody company that provides drug and vaccine development solutions. The company offers pipepline of assets in the therapeutic areas of immuno-oncology, inflammatory disease, haematology, and infectious diseases. Its pipeline products includes KY1003-Anti …
  • American Greetings Corporation:企業の戦略的SWOT分析
    American Greetings Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Dynasil Corporation of America (DYSL)-医療機器分野:企業M&A・提携分析
    Summary Dynasil Corporation of America (Dynasil) is an electronic equipment company that develops and manufactures optics and photonics products. The company also offers optical detection and analysis technology and components. It provides products such as beamsplitters, diffraction gratings, infrar …
  • Crestwood Midstream Partners LP:企業のM&A・事業提携・投資動向
    Crestwood Midstream Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Crestwood Midstream Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Bruce Power L.P.:企業の戦略的SWOT分析
    Bruce Power L.P. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Le Chateau Inc. (CTU):企業の財務・戦略的SWOT分析
    Le Chateau Inc. (CTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • L Brands Inc:戦略・SWOT・企業財務分析
    L Brands Inc - Strategy, SWOT and Corporate Finance Report Summary L Brands Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Western Farmers Electric Cooperative:企業の発電所・SWOT分析2018
    Western Farmers Electric Cooperative - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆